Pfizer is exploring the potential to combine its top selling statin Lipitor (atorvastatin) with its investigational compound CP-529,414 for the treatment of dyslipidaemia.
-
A lack of oxygen supply to the heart leads to adverse clinical consequences... -
Atheroclerosis is a pathological process in which arteries supplying the... -
Pfizer is exploring the potential to combine its top selling statin Lipitor...
